<DOC>
	<DOCNO>NCT01358344</DOCNO>
	<brief_summary>The purpose study determine SCH 530348 2.5 mg tablet contain high percentage drug free base equivalent tablet standard percentage give participant .</brief_summary>
	<brief_title>A Bioequivalence Study SCH 530348 2.5 mg Tablets ( P06558 )</brief_title>
	<detailed_description />
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<mesh_term>Vorapaxar</mesh_term>
	<criteria>Inclusion criterion : Body Mass Index ( BMI ) 18 32 , inclusive Clinical laboratory test within normal limit Free clinically significant disease would interfere study evaluation Screening 12lead electrocardiogram ( ECG ) conduction interval within genderspecific normal range Vital sign measurement within follow range : oral body temperature , 35.0°C 37.5°C ; systolic blood pressure , 90 140 mmHg ; diastolic blood pressure , 45 90 mmHg ; pulse rate , 40 100 beat per minute Female participant must postmenopausal , surgically sterile , abstinent , use medically accept method contraception 3 month prior screen period , trial , 2 month stop trial . Nonvasectomized men must agree use acceptable contraception abstain sexual intercourse trial 3 month stop medication Female participant pregnant , intend become pregnant ( within 3 month end study ) , breastfeed History coagulation disorder ( ) , thrombocytopenia , bleed tendency , ulcer , gastrointestinal bleed History cardiac abnormality include clinically relevant ECGs , frequent palpitation syncopal episodes Any surgical medical condition might significantly alter absorption , distribution , metabolism excretion drug History infectious disease within 4 week prior drug administration Positive hepatitis B surface antigen , hepatitis C antibodies human immunodeficiency virus ( HIV ) Positive screen drug high potential abuse History alcohol drug abuse past 2 year Blood donation past 60 day Previous treatment SCH 530348 Currently participate another clinical study participate clinical study within 30 day Demonstrated allergic reaction Smokes 10 cigarette equivalent tobacco use per day History malignancy Has receive protocoldefined treatment could interfere ability participate trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>